Skip to main content
SpringerLink
Log in

Early postoperative intraperitoneal chemotherapy for gastric cancer

  • Chapter
Management of Gastric Cancer

Part of the book series: Cancer Treatment and Research ((CTAR,volume 55))

Abstract

Gastric cancer remains a major cause of cancer death, despite an unexplained decrease in its incidence in the United States during the past 50 years. Despite recent advances in diagnostic methods, many cases of gastric cancer seen in the hospital are stage II or more advanced [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fujita M, Nakano Y, Ota J, Taguchi T, 1987. Intra-arterial infusion chemotherapy including mitomycin C and 5-fiuorouracil for advanced gastrointestinal cancers. In New Trends in Cancer Chemotherapy with Mitomycin C (Taguchi T. Andrysek O, eds). Tokyo: Excerpta Medica, pp. 89–99.

    Google Scholar 

  2. Gunderson LL, Sosin H, 1982. Adenocarcinoma of the stomach: Areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiation Oncol Biol Phys 8:1–11.

    Article  CAS  Google Scholar 

  3. Bittner R, Beger HG, 1989. New development in surgical oncology. In Cancer Therapy (Beger HG, Buechler M, Reisfeld RA, Schulz G, eds). Berlin: Springer-Verlag, pp. 143–53.

    Chapter  Google Scholar 

  4. Macdonald JS, Steele G Jr., Gunderson LL, 1989. Cancer of the stomach. In Cancer: Principles and Practice of Oncology, 3rd ed (DeVita VT Jr., Hellman S, Rosenberg SA, eds). Philadelphia: J.B. Lippincott Co. pp. 765–99.

    Google Scholar 

  5. Cunliffe WJ, Sugarbaker PH, 1989. Gastrointestinal malignancy: Rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br J Surg 76:1082–1090.

    Article  PubMed  CAS  Google Scholar 

  6. Papachristou DN, Fortner JG, 1981. Local recurrence of gastric adenocarcinoma after gastrectomy. J Surg Oncol 18:47–53.

    Article  PubMed  CAS  Google Scholar 

  7. Jakesz R, Dittrich C, Funovics J, Hofbauer F, Rainer H, Reiner G, Schemper M, Schiessel R, Starlinger M, 1988. The effect of adjuvant chemotherapy in gastric carcinoma is dependent on tumor histology: 5-year results of a prospective randomized trial. Rec Results Cancer Res 110:44–51.

    Article  CAS  Google Scholar 

  8. Iwanaga T, Koyama H, Furukawa H, Taniguchi H, Wada A, Tateishi R, 1978. Mechanisms of late recurrence after radical surgery for gastric carcinoma. Am J Surg 135:637–640.

    Article  PubMed  CAS  Google Scholar 

  9. Maruyama K, Okabayashi K, Kinoshita T, 1987. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 11:418–425.

    Article  PubMed  CAS  Google Scholar 

  10. Nakajima T, Harashima S, Hirata M, Kajitani T, 1978. Prognostic and therapeutic values of peritoneal cytology in gastric cancer. Acta Cytol 22:225–229.

    PubMed  CAS  Google Scholar 

  11. Sugarbaker PH, Cunliffe WJ, Belliveau J, de Bruijn EA, Graves T, Mullins RE, Schlag P, 1989. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol 16(Suppl. 6):83–97.

    PubMed  CAS  Google Scholar 

  12. Sugarbaker PH, Cunliffe W, Belliveau JF, DeBruijn EA, Graves T, Mullins R, Schlag P, Gianola F, 1988. Rationale for perioperative intraperitoneal chemotherapy as a surgical adjuvant for gastrointestinal malignancy. Reg Cancer Treat 1:66–79.

    Google Scholar 

  13. Weiss L, 1985. Principles of Metastasis. Orlando, FL: Academic Press, pp. 134–59.

    Google Scholar 

  14. Douglass HO Jr., 1985. Gastric cancer: Overview of current therapies. Semin Oncol 12(Suppl. 4):57–62.

    PubMed  Google Scholar 

  15. Suit HD, Westgate SJ, 1986. Impact of improved local control on survival. Int J Radiation Oncol Biol Phys 12:453–458.

    Article  CAS  Google Scholar 

  16. Hoover HC, Ketcham AS, 1975. Metastasis of metastases. Am J Surg 130:405–411.

    Article  PubMed  Google Scholar 

  17. Overgaard J, Overgaard M, 1988. Is there a role for hyperthermia in gastrointestinal tract cancer?. Rec Results Cancer Res 110:244–253.

    Article  CAS  Google Scholar 

  18. Yu W, Whang I, 1988. Surgical treatment of gastric cancer. J Korean Med Assoc 31:1153–1160.

    Google Scholar 

  19. Dupont JB Jr., Lee JR, Burton GR, Cohn I Jr., 1978. Adenocarcinoma of the stomach: Review of 1497 cases. Cancer 41:941–947.

    Article  PubMed  Google Scholar 

  20. Nagata T, Ikeda M, Nakayama F, 1983. Changing state of gastric cancer in Japan. Histologic perspective of the past 76 years. Am J Surg 145:226–233.

    Article  PubMed  CAS  Google Scholar 

  21. Nakajima T, Takahashi T, Takagi K, Kuno K, Kajitani T, 1984. Comparison of 5-fluorouracil with ftorafur in adjuvant chemotherapies with combined inductive and maintenance therapies for gastric cancer. J Clin Oncol 2:1366–1371.

    PubMed  CAS  Google Scholar 

  22. Comis RL, Carter SK, 1974. Integration of chemotherapy into combined modality treatment of solid tumors. III. Gastric cancer. Cancer Treat Rev 1:221–238.

    Article  Google Scholar 

  23. Gianola FJ, Sugarbaker PH, Barofsky I, White DE, Meyers CE, 1986. Toxicity studies of adjuvant intravenous versus intraperitoneal 5-FU in patients with advanced primary colon or rectal cancer. Am J Clin Oncol 9:403–410.

    Article  PubMed  CAS  Google Scholar 

  24. Markman M, 1987. Intraperitoneal chemotherapy for malignant diseases of the gastrointestinal tract. Surg Gynecol obstet 164:89–93.

    PubMed  CAS  Google Scholar 

  25. Myers CE, Collins JM, 1983. Pharmacology of intraperitoneal chemotherapy. Cancer Invest 1:395–407.

    Article  PubMed  CAS  Google Scholar 

  26. Wolf BE, Sugarbaker PH, 1988. Intraperitoneal chemotherapy and immunotherapy. Rec Results Cancer Res 110:254–273.

    Article  CAS  Google Scholar 

  27. Litterst CL, Torres IJ, Arnold S, McGunagle D, Furner R, Sikic BI, Guarino AM, 1982. Absorption of antineoplastic drugs following large-volume ip administration to rats. Cancer Treat Rep 66:147–155.

    PubMed  CAS  Google Scholar 

  28. Dedrick RL, Myers CE, Bungay PM, DeVita VT Jr., 1978. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep 62:1–11.

    PubMed  CAS  Google Scholar 

  29. Brenner DE, 1986. Intraperitoneal chemotherapy: A review. J Clin Oncol 4:1135–1147.

    PubMed  CAS  Google Scholar 

  30. Speyer JL, Sugarbaker PH, Collins JM, Dedrick RL, Klecker RW Jr, Myers CE, 1981. Portal levels and hepatic clearance of 5-fiuorouracil after intraperitoneal administration in humans. Cancer Res 41:1916–1922.

    PubMed  CAS  Google Scholar 

  31. Hillcoat BL, McCulloch PB, Figueredo AT, Ehsan MH, Rosenfeld JM, 1978. Clinical response and plasma levels of 5-fiuorouracil in patients with colonic cancer treated by drug infusion. Br J Cancer 38:719–724.

    Article  PubMed  CAS  Google Scholar 

  32. Flessner MF, Fenstermacher JD, Blasberg RG, Dedrick RL, 1985. Peritoneal absorption of macromolecules studied by quantitative autoradiography. Am J Physiol 248.H26–32.

    PubMed  CAS  Google Scholar 

  33. Ozols RF, Young RC, Speyer JL, Sugarbaker PH, Greene R, Jenkins J, Myers CE, 1982. Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer. Cancer Res 42:4265–4269.

    PubMed  CAS  Google Scholar 

  34. Pfeifle CE, Howell SB. Markman M, Lucas WE, 1984. Totally implantable system for peritoneal access. J Clin Oncol 2:1277–1280.

    PubMed  CAS  Google Scholar 

  35. Jenkins J, Sugarbaker PH, Gianola FJ, Myers CE, 1982. Technical considerations in the use of intraperitoneal chemotherapy administered by Tenckhoff catheter. Surg Gynecol Obstet 154:858–864.

    PubMed  CAS  Google Scholar 

  36. Kaplan RA, Markman M, Lucas WE, Pfeifle C, Howell SB, 1985. Infectious peritonitis in 275 patients receiving intraperitoneal chemotherapy. Am J Med 78:49–53

    Article  PubMed  CAS  Google Scholar 

  37. Low DE, Vas SI, Oreopoulos DG, Manuel MA, Saiphoo MM, Finer C, Dombros N, 1980. Prophylactic cephalexin ineffective in chronic ambulatory peritoneal dialysis. Lancet 2:753–754.

    Article  PubMed  CAS  Google Scholar 

  38. Larson DL, 1982. Treatment of tissue extravasation by antitumor agents. Cancer 49:1796–1799.

    Article  PubMed  CAS  Google Scholar 

  39. Speyer JL, Collins JM, Dedrick RL, Brennan MF, Buckpitt AR, Londer H, DeVita VT Jr., Myers CE, 1980. Phase I and pharmacological studies of 5-fluorouracil administered intra-peritoneally. Cancer Res 40:567–572.

    PubMed  CAS  Google Scholar 

  40. Kerr IG, Deangelis C, Assaad DM, Hanna SS, 1987. Drug extravasation along the route of a peritoneal catheter during intraperitoneal chemotherapy. Cancer 60:1731–1733.

    Article  PubMed  CAS  Google Scholar 

  41. Hillan K, Nordlinger B, Ballet F, Puts JP, Infante R, 1988. The healing of colonic anastomoses after early intraperitoneal chemotherapy: An experimental study in rats. J Surg Res 44:166–171.

    Article  PubMed  CAS  Google Scholar 

  42. Machover D, Schwarzenberg L, Goldschmidt E, Tourani JM, Michalski B, Hayat M, Dorval T, Misset JL, Jasmin C, Maral R, Mathe G, 1982. Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: A pilot study. Cancer Treat Rep 66:1803–1807.

    PubMed  CAS  Google Scholar 

  43. Madajewicz S, Petrelli N, Rustum YM, Campbell J, Herrera L, Mittelman A, Perry A, Creaven PJ, 1984. Phase I-II trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer. Cancer Res 44:4667–4669.

    PubMed  CAS  Google Scholar 

  44. Arbuck SG, Douglass HO Jr., Trave F, Milliron S, Baroni M, Nava H, Emrich LJ, Rustum YM, 1987. A phase II trial of 5-fluorouracil and high-dose intavenous leucovorin in gastric carcinoma. J Clin Oncol 5:1150–1156.

    PubMed  CAS  Google Scholar 

  45. Crooke ST, Bradner WT, 1976. Mitomycin C: A review. Cancer Treat Rev 3:121–139.

    Article  PubMed  CAS  Google Scholar 

  46. Douglass HO Jr., Lavin PT, Goudsmit A, Klaassen DJ, Paul AR, 1984. An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277). J Clin Oncol 2:1372–1381.

    PubMed  Google Scholar 

  47. Spratt JS, Adcock RA, Muskovin M, Sherrill W, McKeown J, 1980. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 40:256–260.

    PubMed  CAS  Google Scholar 

  48. Stephens FO, Adams BG, Crea P, 1986. Intra-arterial chemotherapy given preoperatively in the management of carcinoma of the stomach. Surg Gynecol Obstet 162:370–374.

    PubMed  CAS  Google Scholar 

  49. Preusser P, Wilke H, Achterrath W, Fink U, Lenaz L, Heinicke A, Meyer J, Meyer HJ, Buente H, 1989. Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer. J Clin Oncol 7:1310–1317.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Wansik Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul H. Sugarbaker
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Cancer Institute, Washington Hospital Center, Washington, DC, USA

    Paul H. Sugarbaker M.D., FACS

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media New York

About this chapter

Cite this chapter

Yu, W., Sugarbaker, P.H. (1991). Early postoperative intraperitoneal chemotherapy for gastric cancer. In: Sugarbaker, P.H. (eds) Management of Gastric Cancer. Cancer Treatment and Research, vol 55. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3882-0_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3882-0_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6731-4

  • Online ISBN: 978-1-4615-3882-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation